{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:33Z","timestamp":1793321073203,"version":"4.5.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi250449-4\"><jats:title>Importance<\/jats:title><jats:p>Coccidioidomycosis is an underrecognized fungal infection that can cause serious illness and constitutes a considerable public health burden. The number of cases is likely substantially higher than the nationally reported total, as surveillance does not capture patients who do not seek medical care or who are undiagnosed or misdiagnosed. Coccidioidomycosis is not reportable in all states, and cases not reported to public health entities are likewise missed. A systematic estimate of coccidioidomycosis burden is needed to raise awareness and inform public health interventions and policy.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-5\"><jats:title>Objective<\/jats:title><jats:p>To assess the annual burden of symptomatic coccidioidomycosis in the US.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cross-sectional study developed models incorporating coccidioidomycosis cases reported to the National Notifiable Diseases Surveillance System from January 1 to December 31, 2019, as model inputs. Multipliers from US public health surveillance accounted for factors including health care\u2013seeking behavior, underdiagnosis, underreporting, and in-hospital mortality. Multiplier values were sourced from a combination of literature review and expert opinion. Regional estimates were generated using endemicity levels categorized as high (Arizona and California), low (Nevada, New Mexico, Texas, Utah, and Washington), or unknown (all other states and Washington, DC). Data were accrued from January 1, 2022, to July 1, 2024, and analyzed from October 1, 2022, to September 1, 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-7\"><jats:title>Exposure<\/jats:title><jats:p>Coccidioidomycosis reported to public health surveillance entities.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Models estimated annual incident symptomatic coccidioidomycosis cases, hospitalizations, and deaths nationally and regionally in the US.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-9\"><jats:title>Results<\/jats:title><jats:p>A nationwide total of 273\u202f000 (95% credible interval [CrI], 206\u202f000-360 000) incident symptomatic coccidioidomycosis cases were estimated in 2019. High-endemic states accounted for the highest burden (125 000 [95% CrI, 94\u202f000-165 000] cases), followed by states of unknown endemicity (103 000 [95% CrI, 66\u202f000-155 000] cases) and low-endemic states (46 000 [95% CrI, 31\u202f000-65 000] cases). Nationally, models estimated 23\u202f000 annual hospitalizations (95% CrI, 18\u202f000-28 000) and 900 annual deaths (95% CrI, 700-1100) associated with coccidioidomycosis.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi250449-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cross-sectional study, the estimated national burden of symptomatic coccidioidomycosis in 2019 was 10 to 18 times higher than the number of cases reported through national surveillance. Better awareness, diagnostic testing practices, and reporting are needed to improve patient outcomes and enhance our understanding of coccidioidomycosis epidemiology.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.13572","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:00:41Z","timestamp":1748948441000},"page":"e2513572","source":"Crossref","is-referenced-by-count":46,"title":["Estimated Burden of Coccidioidomycosis"],"prefix":"10.1001","volume":"8","author":[{"given":"Samantha L.","family":"Williams","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Benedict","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R.","family":"Jackson","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malavika","family":"Rajeev","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Cooksey","sequence":"additional","affiliation":[{"name":"California Department of Public Health, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ruberto","sequence":"additional","affiliation":[{"name":"Arizona Department of Health Services, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Williamson","sequence":"additional","affiliation":[{"name":"Arizona Department of Health Services, Phoenix"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Sunenshine","sequence":"additional","affiliation":[{"name":"Maricopa County Department of Public Health, Phoenix, Arizona"},{"name":"Career Epidemiology Field Officer Program, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BreAnne","family":"Osborn","sequence":"additional","affiliation":[{"name":"Utah Department of Health and Human Services, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna N.","family":"Oltean","sequence":"additional","affiliation":[{"name":"Washington State Department of Health, Shoreline"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Reik","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Freedman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Spec","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Washington University in St Louis School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Carey","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan S.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Medina-Garcia","sequence":"additional","affiliation":[{"name":"University Medical Center of Southern Nevada, Las Vegas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan C.","family":"Bahr","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis"},{"name":"Division of Infectious Diseases, Department of Medicine, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Kuran","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kern Medical Center\u2013UCLA (University of California, Los Angeles), Bakersfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Heidari","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, UCLA, Los Angeles"},{"name":"Morehouse School of Medicine, Atlanta, Georgia"},{"name":"Bakersfield Memorial Hospital, Dignity Health, Bakersfield, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California Davis Medical Center, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kern Medical Center\u2013UCLA (University of California, Los Angeles), Bakersfield"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Galgiani","sequence":"additional","affiliation":[{"name":"Valley Fever Center for Excellence, Departments of Medicine and Immunobiology, College of Medicine\u2013Tucson, BIO5 Institute, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Toda","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"5","key":"zoi250449r1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses.","volume":"185","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"},{"issue":"8","key":"zoi250449r2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3201\/eid2408.171595","article-title":"Enhanced surveillance for coccidioidomycosis, 14 US states, 2016.","volume":"24","author":"Benedict","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"zoi250449r3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3201\/eid1611.100475","article-title":"Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008.","volume":"16","author":"Tsang","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"zoi250449r4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac097","article-title":"Economic burden of fungal diseases in the United States.","volume":"9","author":"Benedict","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"zoi250449r6","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.7326\/M22-2371","article-title":"Endemic mycoses: underdiagnosed and underreported.","volume":"175","author":"Thompson","year":"2022","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi250449r9","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3201\/eid1709.101987","article-title":"Geographic distribution of endemic fungal infections among older persons, United States.","volume":"17","author":"Baddley","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"zoi250449r10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3201\/eid2509.190023","article-title":"Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA.","volume":"25","author":"Donovan","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"zoi250449r11","doi-asserted-by":"publisher","first-page":"e4336","DOI":"10.1093\/cid\/ciaa1554","article-title":"Symptoms in blastomycosis, coccidioidomycosis, and histoplasmosis versus other respiratory illnesses in commercially insured adult outpatients-United States, 2016-2017.","volume":"73","author":"Benedict","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi250449r12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab020","article-title":"Health care providers\u2019 testing practices for coccidioidomycosis and histoplasmosis in patients with community-acquired pneumonia\u2014United States, 2020.","volume":"8","author":"Benedict","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"zoi250449r13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3390\/jof7080605","article-title":"Testing practices for fungal respiratory infections and SARS-CoV-2 among infectious disease specialists, United States.","volume":"7","author":"Benedict","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"zoi250449r14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3109\/13693786.2010.547995","article-title":"Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers\u2014Arizona, 2007.","volume":"49","author":"Chen","year":"2011","journal-title":"Med Mycol"},{"key":"zoi250449r15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad619","article-title":"Clinical testing guidance for coccidioidomycosis, histoplasmosis, and blastomycosis in patients with community-acquired pneumonia for primary and urgent care providers.","author":"Smith","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi250449r16","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01581-22","article-title":"Review of clinical and laboratory diagnostics for coccidioidomycosis.","volume":"61","author":"McHardy","year":"2023","journal-title":"J Clin Microbiol"},{"issue":"9","key":"zoi250449r17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis.","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"zoi250449r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7107a1","article-title":"Surveillance for coccidioidomycosis, histoplasmosis, and blastomycosis\u2014United States, 2019.","volume":"71","author":"Smith","year":"2022","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"zoi250449r20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1378\/chest.31.1.35","article-title":"Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin.","volume":"31","author":"Edwards","year":"1957","journal-title":"Dis Chest"},{"issue":"1","key":"zoi250449r21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciu681","article-title":"Valley fever: finding new places for an old disease: Coccidioides immitis found in Washington State soil associated with recent human infection.","volume":"60","author":"Litvintseva","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi250449r22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3201\/eid1004.030446","article-title":"Coccidioidomycosis among workers at an archeological site, northeastern Utah.","volume":"10","author":"Petersen","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"zoi250449r25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States\u2014major pathogens.","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"zoi250449r26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3201\/eid2701.190676","article-title":"Estimate of burden and direct healthcare cost of infectious waterborne disease in the United States.","volume":"27","author":"Collier","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"zoi250449r27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40121-022-00606-y","article-title":"Coccidioidomycosis: a contemporary review.","volume":"11","author":"Crum","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"10","key":"zoi250449r28","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/MLR.0b013e318185c913","article-title":"The causal effect of health insurance on utilization and outcomes in adults: a systematic review of US studies.","volume":"46","author":"Freeman","year":"2008","journal-title":"Med Care"},{"issue":"4 pt 1","key":"zoi250449r29","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1164\/ajrccm.157.4.9709071","article-title":"Why do symptomatic patients delay obtaining care for tuberculosis?","volume":"157","author":"Asch","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"zoi250449r30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2105\/AJPH.2009.190892","article-title":"Impact of individual-, environmental-, and policy-level factors on health care utilization among US farmworkers.","volume":"101","author":"Hoerster","year":"2011","journal-title":"Am J Public Health"},{"issue":"3","key":"zoi250449r32","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1093\/cid\/ciac489","article-title":"Increased deaths from fungal infections during the coronavirus disease 2019 pandemic\u2014National Vital Statistics System, United States, January 2020-December 2021.","volume":"76","author":"Gold","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi250449r33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/mmy\/myx041","article-title":"Coccidioidomycosis: an underreported cause of death\u2014Arizona, 2008-2013.","volume":"56","author":"Jones","year":"2018","journal-title":"Med Mycol"},{"issue":"7","key":"zoi250449r34","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3201\/eid1407.070832","article-title":"Testing for coccidioidomycosis among patients with community-acquired pneumonia.","volume":"14","author":"Chang","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"zoi250449r35","doi-asserted-by":"publisher","author":"Kim","journal-title":"Emerg Infect Dis","DOI":"10.3201\/eid1503.081007"},{"issue":"6","key":"zoi250449r36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3201\/eid1206.060028","article-title":"Coccidioidomycosis as a common cause of community-acquired pneumonia.","volume":"12","author":"Valdivia","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"zoi250449r5","unstructured":"Centers for Disease Control and Prevention. Valley fever (coccidioidomycosis): reported cases of Valley fever. Types of fungal diseases. Accessed September 16, 2024. https:\/\/www.cdc.gov\/valley-fever\/php\/statistics\/index.html"},{"key":"zoi250449r7","unstructured":"Centers for Disease Control and Prevention. Reportable Fungal Diseases by State. Accessed September 16, 2024. https:\/\/www.cdc.gov\/fungal\/php\/case-reporting\/index.html"},{"key":"zoi250449r8","unstructured":"Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. November 20, 2024. Accessed September 16, 2024. https:\/\/www.cdc.gov\/nndss\/about\/index.html"},{"key":"zoi250449r18","unstructured":"Council of State and Territorial Epidemiologists. Coccidioidomycosis\/Valley fever (Coccidioides spp.) 2011 case definition. Accessed September 16, 2024. https:\/\/ndc.services.cdc.gov\/case-definitions\/coccidioidomycosis-2011\/"},{"key":"zoi250449r23","unstructured":"Protection of human subjects. 45 CFR \u00a746 (2025). Accessed April 21, 2025. https:\/\/www.ecfr.gov\/current\/title-45\/subtitle-A\/subchapter-A\/part-46"},{"key":"zoi250449r24","unstructured":"Institutional review boards. 21 CFR \u00a756 (2025). Accessed April 21, 2025. https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-A\/part-56"},{"key":"zoi250449r31","unstructured":"Healthcare Cost and Utilization Project. User support. Updated February 5, 2025. Accessed December 20, 2023. https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834845\/williams_2025_oi_250449_1752004141.3508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:00:37Z","timestamp":1752505237000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.13572","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}